robert-m-califf documents

Experience with the use of tPA in the treatment of acute myocardial infarction
Documents Experience with the use of tPA in the treatment of acute myocardial infarction
Benefit assessment of therapeutic products: the Centers for Education and Research on Therapeutics
Documents Benefit assessment of therapeutic products: the Centers for Education and Research on Therapeutics
The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment
Documents The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment
The need for a national infrastructure to improve the rational use of therapeutics
Documents The need for a national infrastructure to improve the rational use of therapeutics
Benefit the patient, manage the risk: a system goal
Documents Benefit the patient, manage the risk: a system goal
Evaluating the costs and effectiveness of cardiovascular therapies: who cares about economic analyses?
Documents Evaluating the costs and effectiveness of cardiovascular therapies: who cares about economic analyses?
New Agents, New Trials, New Solutions
Documents New Agents, New Trials, New Solutions
Clinical risks of thrombolytic therapy
Documents Clinical risks of thrombolytic therapy
Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT]
Documents Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT]
The coxib story: some lessons and more questions
Documents The coxib story: some lessons and more questions
Introduction: evidence to practice in acute coronary syndromes
Documents Introduction: evidence to practice in acute coronary syndromes
Use of calcium channel antagonists in myocardial revascularization procedures
Documents Use of calcium channel antagonists in myocardial revascularization procedures
How Much Do We Gain by Reducing Time to Reperfusion Therapy?
Documents How Much Do We Gain by Reducing Time to Reperfusion Therapy?
A perspective on the regulation of the evaluation of new antithrombotic drugs
Documents A perspective on the regulation of the evaluation of new antithrombotic drugs
Implications for cost-effectiveness
Documents Implications for cost-effectiveness
Implications for cost-effectiveness
Documents Implications for cost-effectiveness
Toward protecting the safety of participants in clinical trials
Documents Toward protecting the safety of participants in clinical trials
Developing systems for cost-effective auditing of clinical trials
Documents Developing systems for cost-effective auditing of clinical trials
Restenosis: The cost to society
Documents Restenosis: The cost to society
Prognostic value of ventricular arrhythmias
Documents Prognostic value of ventricular arrhythmias
Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery disease
Documents Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery disease